© Reuters.
Scientists from Utrecht University have managed to recreate the cure for Pompe disease. It’s only a small amount and should be more testing, but it is estimated that it is ready within two years for patients. About post as the research Argos today.
The cure for muscular, Myozyme manufacturer Genzyme is very expensive: it costs around 400,000 to 700,000 euros per patient per year. It means they’re working on in Utrecht, is making for 4,000 euros. That treasure Professor Huub Schellekens, initiator of the investigation.
Manufacturer Genzyme wait, Argos reported in the broadcast. The investments to make the drug amount to 1.3 billion euros, announced a spokesman for the group. Profit is not made. But if the university succeeds it means “on the same scale with a similar quality and effectiveness continuously” produce “is of course a great achievement.” And, “When that also would come associated with lower costs, would mean an incredible milestone in biotechnological production.”
No comments:
Post a Comment